Safe Harbor Clinical Research — East Providence, Rhode Island

Safe Harbor Clinical Research is a clinical research site located in East Providence, Rhode Island, United States 02914.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Safe Harbor Clinical Research has participated in 18 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus, Lung Cancer (Diagnosis).

Sponsors: AstraZeneca, Exact Sciences Corporation, Oxford Immunotec.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Safe Harbor Clinical Research?

Safe Harbor Clinical Research has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Safe Harbor Clinical Research conducted?

Safe Harbor Clinical Research has 18 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus, Lung Cancer (Diagnosis).

Is Safe Harbor Clinical Research accredited by Crixeo Health?

Yes — Safe Harbor Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Safe Harbor Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.